A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
Conditions: DLBCL; Diffuse Large B Cell Lymphoma Interventions: Drug: R-pola-mini-CHP; Drug: R-mini-CHOP Sponsors: Nordic Lymphoma Group; Roche Pharma AG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials